Litcius/Paper detail

Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease

Ashok Iyaswamy, Senthil Kumar Krishnamoorthi, Huan Zhang, Sravan Gopalkrishnashetty Sreenivasmurthy, Zhou Zhu, Jia Liu, Cheng-Fu Su, Xinjie Guan, Ziying Wang, King‐Ho Cheung, Ju‐Xian Song, Siva Sundara Kumar Durairajan, Min Li

2021Phytomedicine41 citationsDOI

Topics & Concepts

NeuroprotectionAutophagyGenetically modified mousePharmacologyTFEBChemistryIn vivoNeuroscienceCell biologyTransgeneBiologyBiochemistryBiotechnologyGeneApoptosisAlzheimer's disease research and treatmentsPeroxisome Proliferator-Activated ReceptorsAutophagy in Disease and Therapy
Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease | Litcius